Press release
Global Anticoagulant Reversal Drugs Market Size & Share Is Projected to Grow Around $ 2.25 Bn By 2030
The global anticoagulant reversal drugs market size is worth around US$ 0.83 Billion in 2021 and is projected to grow around USD 2.25 Billion by 2030, with a compounded annual growth rate (CAGR) of roughly 11.27% from 2022 to 2030.Anticoagulants are medications that are essentially used to ward off the layer of blood from getting thick. Anticoagulants play a major role in helping patients suffering from lethal conditions including pulmonary embolisms and heart attacks. Several reversal agents such as Xarelto and Eliquis are extensively used to counter the effect of severe situations of uncontrolled and prolonged bleeding.
Browse Press Release - https://www.zionmarketresearch.com/news/global-anticoagulant-reversal-drugs-market
Vitamin K or Praxbind (idarucizumab) is another such medication that is given to prevent anticoagulants from working, and hence it has been approved for emergency situations.
The demand for anticoagulant reversal drugs is expected to surge exponentially due to an increase in cases of bleeding disorders and abnormal blood coagulation among people. Gastrointestinal (GI) hemorrhage and intracranial hemorrhage (ICH) are becoming more and more prevalent among people. Besides, the increase in cases of heart attacks and the surge in the geriatric population further drive the growth of the global anticoagulant reversal drugs market.
In addition, an increase in the adoption of new technologies, the development of novel medications, and the increase in R&D activities for effective drug development procedures by prominent players in the market create ample opportunities for the growth of the anticoagulant reversal drugs industry. On the other hand, the high cost of drugs and various complications regarding the side effects of the drugs restrict the growth of the market to an extent.
>>> Get | Download Free Sample Report @ - https://www.zionmarketresearch.com/sample/anticoagulant-reversal-drugs-market
The global anticoagulant reversal drugs market is segmented into product type, distribution channel, and region.
Based on product type, the global market is bifurcated into idarucizumab, protamine, prothrombin complex concentrates, coagulation factors, phytonadione, andexanet alfa, and others. The coagulation factors segment held the largest market share in 2021 and is further expected to surge exponentially at a promising CAGR during the forecast period.
This segment is driven by increased cases of blood clotting during COVID-19 in most of the patients. Hence, coagulopathy of differing extremities was witnessed in most of the COVID-19-infected patients. This marked the exponential growth of this segment. On the other hand, the andexanet alfa segment is anticipated to grow at a promising CAGR during the forecast period.
This is mainly due to the approval and launch of andexanet alfa in key markets as a remarkable reimbursement scenario for andexanet alfa is witnessed in the market that drives the growth of the segment during the forecast period.
Based on distribution channel, the global market is bifurcated into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment held the largest market share in 2021 and is further predicted to grow rapidly at a significant CAGR during the forecast period.
The growth of this segment is because hospitals are the key diagnostic and treatment sites for different kinds of bleeding disorders, and hence cases of immoderate bleeding during critical situations are further driving the growth of the segment. On the other hand, the retail pharmacy segment held the second-largest market share in 2021 and is further predicted to grow at a promising CAGR during the forecast period.
Based on region, the North American region held the dominating market share in 2021 and is further predicted to grow at a promising CAGR during the forecast period. The major reason for the growth of the market is the presence of prominent players, the rise in geriatric populations, expensive healthcare, the prevalence of different types of bleeding disorders among people, the increase in R&D activities, and the presence of advanced healthcare infrastructure in this region.
This review is based on a report by Zion Market Research, titled "Anticoagulant Reversal Drugs Market By Product Type (Idarucizumab, Protamine, Prothrombin Complex Concentrates, Coagulation Factors, Phytonadione, Andexanet Alfa, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2030."- Report at https://www.zionmarketresearch.com/report/anticoagulant-reversal-drugs-market
Recent Developments:
In March 2022, Ondexxya became the first approved reversal agent in Japan for patients who are undergoing the treatment of Factor Xa inhibitors rivaroxaban, apixaban, or edoxaban, where reversal of anticoagulation is of paramount importance because of lethal or immoderate bleeding. The approval of the drug was done by the Japanese Ministry of Health, Labour and Welfare by following the remarkable conclusions on favorable results from the ANNEXA-4 Phase III clinical trial that portrayed Ondexxya considerably reversing anti-FXa activity in patients who suffered from lethal bleeding. Japan also became the first country to facilitate complete regulatory approval of Ondexxya for use. This provides a key advancement in the diagnosis of patients who are hospitalized and suffering from pernicious bleeding.
In July 2022, a team led by a UNC Charlotte researcher named Kirill Afonin announced the launch of a new anticoagulant platform that can be beneficially used during dialysis, heart surgeries, and other procedures for better treatment of patients.
The global anticoagulant reversal drugs market is dominated by players such as:
Pfizer Inc.
AstraZeneca
Bristol-Myers Squibb Company
Dr. Reddy's Laboratories Ltd
Endo International plc
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Mylan N.V.
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma
Sanofi
Merck & Co. Inc
Amneal Pharmaceuticals LLC.
Alvogen
Bausch Health Companies Inc.
The global anticoagulant reversal drugs market is segmented as follows:
By Product Type
Idarucizumab
Protamine
Prothrombin Complex Concentrates
Coagulation Factors
Phytonadione
Andexanet Alfa
Others
Request Customized Copy Of Report @ https://www.zionmarketresearch.com/custom/6104
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
FREQUENTLY ASKED QUESTIONS
Which key factors will influence the global anticoagulant reversal drugs market growth over 2022-2030?
What will be the value of the global anticoagulant reversal drugs market during 2022-2030?
Which region will contribute notably towards the anticoagulant reversal drugs market value?
Which are the major players leveraging the global anticoagulant reversal drugs market?
Why Choose Zion Market Research?
Serving domestic and international clients 24/7
Prompt and efficient customer service
Data collected from reliable primary and secondary sources
Highly trained and experienced team of research analysts
Seamless delivery of tailor-made market research reports
Check out my latest article:
Global Champagne Market To Grow At A CAGR Of 3.5% By 2030
https://www.zionmarketresearch.com/news/global-champagne-market
Global Refrigerated/Frozen Dough Products Market To Grow At A CAGR Of 5.5% By 2030
https://www.zionmarketresearch.com/news/global-refrigerated-frozen-dough-products-market
Global Tangential Flow Filtration Market to Grow at a CAGR of 13.15% by 2030
https://www.zionmarketresearch.com/news/global-tangential-flow-filtration-market
Global Eubiotics Market to Grow at a CAGR of 7.43% by 2030
https://www.zionmarketresearch.com/news/global-eubiotics-market
Global Decentralized Finance (DeFi) Market Revenue To Hit Nearly $232.20 Billion By 2030
https://www.zionmarketresearch.com/news/global-decentralized-finance-market
Global Corporate Travel Market Revenue Is Set To Increase To About $2,997.2 Billion By 2030
https://www.zionmarketresearch.com/news/global-corporate-travel-market
Global Online Grocery Delivery Services Market Revenue Is Set To Increase To About $2,159 Billion By 2030
https://www.zionmarketresearch.com/news/global-online-grocery-delivery-services-market
https://www.globalnewsscanner.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.asiapacificnewstoday.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.oneworlddailybrief.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.medicalbudnews.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.niueindustrybrief.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.eyeballsandclicks.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.smbworldreport.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.niueentertainmenthub.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.globaljournalobserver.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.smbinaction.com/article/609641892-global-concrete-admixture-market-is-likely-to-grow-at-a-cagr-value-of-around-5-9-by-2028-zmr
https://www.linkedin.com/m/pulse/global-virtual-reality-market-size-share-growth-outlook-maria-howard
https://www.linkedin.com/m/pulse/global-mobile-point-sale-mpos-market-size-industry-trends-howard
https://www.linkedin.com/m/pulse/global-virtual-mobile-infrastructure-market-look-future-maria-howard/
https://www.linkedin.com/m/pulse/landscape-data-quality-tools-market-outlook-zmr-report-maria-howard
https://www.linkedin.com/pulse/global-customer-relationship-management-services-market-maria-howard/
https://www.linkedin.com/pulse/global-communications-platform-service-cpaas-market-share-howard/
https://www.linkedin.com/pulse/global-building-information-modeling-bim-market-size-share-howard-1f/
https://www.linkedin.com/pulse/87-cagr-global-enterprise-data-management-market-size-maria-howard/
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Read Blog - https://zmrblog.com/
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Anticoagulant Reversal Drugs Market Size & Share Is Projected to Grow Around $ 2.25 Bn By 2030 here
News-ID: 2924154 • Views: …
More Releases from Zion Market Research
Pharmaceutical Plastic Bottles Market Size to Reach USD 49.72 Billion by 2034, G …
The global pharmaceutical plastic bottles market continues to gain momentum as the pharmaceutical and healthcare industries increasingly prioritize lightweight, durable, and cost-effective packaging solutions. Valued at USD 30.52 billion in 2024, the market is projected to reach approximately USD 49.72 billion by 2034, expanding at a steady CAGR of 5% during the forecast period (2025-2034).
Pharmaceutical plastic bottles are increasingly replacing traditional glass containers due to their superior safety, convenience, and…
Building Panels Market Size to Reach USD 421.41 Billion by 2034, Growing at a CA …
The global building panels market is experiencing strong momentum as the construction industry increasingly embraces faster, sustainable, and cost-efficient building methods. Valued at USD 228.54 billion in 2024, the market is projected to soar to USD 421.41 billion by 2034, expanding at a steady CAGR of 6.3% during the forecast period (2025-2034).
Building panels - used across residential, commercial, and industrial structures - are manufactured from a range of materials, including…
Vessel Traffic Management Market Size to Reach USD 15.51 Billion by 2034, Growin …
The global vessel traffic management (VTM) market is on a strong growth trajectory, valued at USD 6.93 billion in 2024 and projected to surpass USD 15.51 billion by 2034, expanding at a CAGR of 8.4% between 2025 and 2034. The market is witnessing steady growth due to the rising need for safe navigation, maritime trade expansion, and smart port technology adoption across the globe.
Vessel traffic management systems play a crucial…
Global Plastic Waste Management Market To Surpass USD 64.02 Billion by 2034, Dri …
The global plastic waste management market was valued at USD 38.56 Billion in 2024 and is projected to reach approximately USD 64.02 Billion by 2034, growing at a CAGR of 5.2% between 2025 and 2034. The industry's growth is fueled by increasing environmental awareness, stringent government regulations, and the rise of circular economy practices across both developed and emerging economies.
Plastic waste management has evolved into one of the most crucial…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
